相关实验视频
Updated: Jun 25, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
抑制SGLT2以向脏衰老的目标
Elisa Russo1,2, Valentina Zanetti1, Lucia Macciò1
1Department of Internal Medicine, University of Genoa, Genoa, Italy.
-葡萄糖共载体2抑制剂 (SGLT2is) 在慢性病 (CKD) 的抗衰老疗法中表现有前途. 这些药物可以抵消细胞衰老和炎症,可能减缓脏衰老中的CKD进展.
科学领域:
- 老年学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 和衰老具有共同的特征,如细胞衰老,炎症和氧化应激.
- 参与衰老和CKD的细胞信号通路提供了潜在的治疗点.
- -葡萄糖共载体2抑制剂 (SGLT2is) 在整个心脏和脏频谱中表现出显著的益处.
研究的目的:
- 审查SGLT2is对脏衰老和衰老相关的分子通路的影响的实验证据.
- 探索SGLT2is在减轻脏衰老和衰老相关损伤方面的潜力.
- 阐明SGLT2is在老化背景下控制CKD进展中的作用.
主要方法:
- 实验研究的文献评论.
- 对参与细胞衰老和衰老的分子途径的分析.
- 检查SGLT2is对这些途径的影响.
主要成果:
- SGLT2is对调节衰老,衰老和细胞损伤的分子通路产生影响.
- 有证据表明,SGLT2is可以抵消与CKD相关的关键衰老过程.
- SGLT2对脏的益处的确切机制仍在调查中.
结论:
- SGLT2具有作为治疗治疗衰老和慢性病的治疗策略的潜力.
- 用SGLT2is准衰老和衰老途径可能会减少CKD的进展.
- 需要进一步的研究,以充分理解和优化SGLT2在护理中的作用.
更多相关视频
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
相关概念视频
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drug Elimination by Renal Route: Tubular Secretion
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors